R01: Genetic Origins of Adverse Outcomes in African Americans with Lymphoma
Research Grant
Administered By
Medicine, Hematologic Malignancies and Cellular Therapy
Awarded By
National Institutes of Health
Start Date
April 18, 2023
End Date
March 31, 2028
Administered By
Medicine, Hematologic Malignancies and Cellular Therapy
Awarded By
National Institutes of Health
Start Date
April 18, 2023
End Date
March 31, 2028